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Epithelial to mesenchymal transition (EMT) is a fundamental mechanism of organ fibrosis and the initial step is disruption of cell junction and cell
polarity. TGF-β has been demonstrated as the most important mediator of EMTwhich is sufficient to initiate and complete the whole course of EMT,
however, the detailed mechanism of TGF-β in modulating the disruption of cell junction still remains unclear. Par-3 is a component of Par complex
which plays a crucial role in the establishment andmaintenance of epithelial polarity. In this study, we found that TGF-β treatment resulted in a dose- and
time-dependent downregulation of Par-3 protein together with the suppression of E-cadherin expression and induction of α-SMA. The decreased Par-3
subsequently resulted in the redistribution of Par-6–aPKC complex from cell membrane to cytoplasm. Forced expression of exogenous Par-3 into rat
proximal epithelial cells (NRK52E) led to a drastic blockage of TGF-β1-inducedE-cadherin suppression andα-SMA induction. In contrast, knockdown
Par-3 expression by siRNA significantly enhanced TGF-β1-induced E-cadherin suppression and α-SMA induction. These data indicate that
downregulation of Par-3 and subsequent disruption of Par complex integrity might be one mechanism that TGF-β destroys cell polarity during EMT.
© 2007 Elsevier B.V. All rights reserved.Keywords: Par-3; Par complex; Cell junction; Epithelial to mesenchymal transition; TGF-β1; Proximal epithelial cell1. Introduction
In mature tubular epithelial cells, apical–basal polarity is
maintained through the formation of several intercellular adhesion
systems consisting of adhesion junctions, desmosomes, and tight
junctions. The tight junction segregates the plasma membrane
into structurally and functionally distinct basal and apical do-
mains and the distribution of protein and lipid molecules in
epithelial cells is asymmetric in these two domains, which is
required for proper polarization of epithelial cells [1–3]. How-
ever, these extremely differentiated epithelial cell phenotypes are
not unchangeable. Under certain stimulations, differentiated epi-
thelial cells can switch on a mesenchymal genetic program and
formmesenchymal-like cells through the process called epithelial
to mesenchymal transition (EMT) [4].⁎ Corresponding author. Tel./fax: +86 20 87769673.
E-mail address: yuxq@mail.sysu.edu.cn (X. Yu).
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doi:10.1016/j.bbadis.2007.11.002EMT is characterized by the disruption of epithelial junctions,
loss of cell polarity, remodeling of actin cytoskeleton, alteration
of cell–matrix adhesion, and increase in cell motility. EMT is a
complex process, resulting from the interplay between numerous
growth factors, cytokines, hormones, and extracellular cues.
Among them, TGF-β is a sole factor which is sufficient to
initiate and complete the whole course of EMT. TGF-β signals
through type I (TβRI) and type II (TβRII) transmembrane
receptors. Constitutive active TβRII activates TβRI, which in
turn phosphorylates Smad2/3. Smad2/3 then binds to Smad4 and
translocated into nucleus, where they regulate target gene tran-
scription [5,6]. It has been postulated that EMT at the cellular
level occurs in a stepwise fashion. The earliest event of EMT is
the disruption of cell junction, which manifests as the sup-
pression of E-cadherin expression [7]. However, the exact
molecular mechanism that TGF-β results in the disruption of
cell–cell junctions remains unclear.
Recently, a signaling complex comprised of three proteins,
partitioning-defective 3 (Par-3), Par-6 and atypical PKC (aPKC),
Fig. 2. TGF-β1 suppresses Par-3 expression in a dose-dependent manner.
(A) Western blot analysis was performed to examine the protein level of Par-3 in
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junctions during adhesion-mediated cell polarization in various
organisms ranging from worms to mammals [8–10]. The three
proteins interact with each other to form a ternary complex and
thus mutually regulate their functionality and localization [11].
The Par-3–Par-6–aPKC ternary complex (Par complex) was first
identified in Caenorhabditis elegans as indispensable for the
establishment of anterior/posterior polarity at the one-cell em-
bryonic stage [12]. In Drosophila neuroblasts and epithelia, this
protein complex localizes to the subapical regions, and plays a
critical role in the establishment of apical–basal membrane
polarity [13–15]. In mammalian epithelial cells, the complex
localizes to the tight junction [16–18]. Studies using cultured
epithelial cells demonstrated that the Par complex promotes theFig. 1. TGF-β1 suppressed Par-3 expression in NRK52E cells. (A) Western
blot analysis was performed to examine the expression of Par-3, E-cadherin
and α-SMA in NRK52E cells treated with 10 ng/ml TGF-β1 over 72 h. A
decrease of Par-3 expression was found at 48 h and became more significant at
72 h after TGF-β1 treatment. GAPDH was used to verify equivalent loading.
(B) Graphic presentation of relative abundance of Par-3, E-cadnerin and α-SMA
normalized toGAPDH.Datawas given asmean±SDvalues of three independent
experiments. ⁎pb0.05 compared to untreated group.
NRK52E cells treatedwith various dose of TGF-β1 for 72 h. The decrease of Par-
3 expression became significant at 10 ng/ml TGF-β1 treatment. GAPDH was
used to verify equivalent loading. (B) Graphic presentation of relative abundance
of Par-3 normalized to GAPDH. Data was given as mean±SD values of three
independent experiments. ⁎pb0.05, ⁎⁎pb0.01 compared to untreated group.formation of epithelial tight junctions and thereby contributes to
the establishment and maintenance of apical–basal polarity [17–
19]. Considering the critical role of the Par complex in epithelial
cell polarity, we hypothesize that TGF-β regulates the expression
and/or the integrity of this complex during the process of EMT. To
test this hypothesis, we have investigated the effect of TGF-β1 on
the expression of Par-3, a key component of Par complex and the
integrity of Par complex. Additionally, we examined the effect of
overexpression of Par-3 on TGF-β1-induced EMT in rat proximal
tubular epithelial cells.
2. Materials and methods
2.1. Reagents
Normal rat kidney epithelial (NRK52E) cells were purchased from
American Type Culture Collection (Manassas, VA); Dulbecco's modified
Eagle's medium (DMEM), fetal bovine serum (FBS) and trypsin/EDTA solution
were purchased from Invitrogen (Carlsbad, CA); recombinant human TGF-β1
(R&D Systems), TRIzol and reverse transcriptase were from Invitrogen
(Carlsbad, CA, USA); Monoclonal mouse anti-HA antibody was from Roche
(Indianapolis, IN), antibody against E-cadherin was from BD Biosciences (San
Jose, CA), anti α-SMA (smooth muscle actin) was from DakoCytomation
(Denmark), polyclonal anti-Par-3 antibody was from Upstate BiotechnologiesFig. 3. TGF-β1 suppresses Par-3 expression at mRNA level. Bar graphs show
averages of relative Par-3 mRNA abundance determined by quantitative RT-
PCR in NRK52E cells treated with 10 ng/ml TGF-β1 at indicated time points.
Data was given as mean±SD values of three independent experiments.
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Santa Cruz Biotechnology Inc.(Santa Cruz, CA). pKH3-HA-Par-3b was a gift
from Dr. Ian G. Macara (University of Virginia, Charlottesville, VA).
2.2. Cell culture and transfection
NRK52E cells were grown in DMEMmedium supplemented with 10% FBS
at 37 °C in a humidified 5% CO2 incubator. When 60% confluent, cells were
cultured in serum free medium for 24 h before TGF-β1 treatment.
For transient transfection, cells were transfected with 1 μg plasmid DNA
with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. To detect the expression of Par-3, cellular lysates
were harvested 48 h after transfection. To examine the effect of overexpressedFig. 4. Expression and localization of Par-3, E-cadherin and α-SMA in NRK52E cells
and B: The epithelial morphology of these cells changed dramatically into fibroblast-l
on the cellular membrane was decreased after 72 h TGF-β1 treatment. Plots E and F:
H: The staining of Par-3 at cellular membrane was decreased, but diffused cytosolic s
confocal microscopy.Par-3 on TGF-β1-induced EMT, NRK52E cells were transfected with 1 μg of
pKH3-HA-Par-3 and then cultured in serum free medium for 24 h before TGF-
β1 treatment. Cellular lysates were harvested 72 h after TGF-β1 treatment. To
knockdown Par-3 expression, 4 μg/ml of siRNAwas transfected. The sequence
of Par-3 siRNA is: 5-GGC AUG GAG ACC UUG GAA GTT-3.
Stable transfectants were generated from NRK52E cells after selection with
G418 800μg/ml. Ectopic expression of Par-3 in the stable cell linewas confirmed
by Western blot.
2.3. Real-time PCR
Real-time PCR was performed with the ABI PRISM 7000 sequence
detection system. SYBR green real-time PCR mix (Invitrogen, Carlsbad, CA)after TGF-β1 treatment when assessed by immunofluorescence staining. Plots A
ike after TGF-β1 treatment for 72 h. Plots C and D: The expression of E-cadherin
α-SMA expression was significantly induced by TGF-β1 treatment. Plots G and
taining for Par-3 was detected after TGF-β1 treatment. Images were obtained by
Fig. 5. (A) TGF-β1 treatment did not change the protein level of Par-6 and aPKC
but redistribute them into the cytoplasm. The expression of GAPDH was
analyzed as a loading control. NRK52E cells cultured with or without TGF-β1
for 72 h were harvested by lysis buffer and then subjected to Western blot
analysis with indicated antibodies. (B) TGF-β1 treatment caused the redis-
tribution of Par-6 to the cytoplasm. NRK52E cells cultured with or without
TGF-β1 treatment for 72 h were harvested by either lysis buffer or NP-40 IP
buffer and then subjected to Western blot analysis with anti-Par-6 antibody. The
expression of β-actin was analyzed in the same sample as a loading control. I,
whole cell lysates from TGF-β1-untreated cells; II, whole cell lysates from
TGF-β1-treated cells; III, NP-40 insoluble fraction from TGF-β1-untreated
cells; IV, NP-40 insoluble fraction from TGF-β1-treated cells. V, NP-40 soluble
fraction from TGF-β1-untreated cells. VI, NP-40 soluble fraction from TGF-β1-
treated cells. (C) TGF-β1 disassembled Par complex. NRK52E cells cultured
with or without TGF-β1 for 72 h were harvested by lysis buffer and proteins
separated by centrifugation. The supernatants were collected and 1 mg protein
was subjected to immunoprecipitation with anti-Par-6 antibody and precipitated
protein was analyzed byWestern blot analysis using either anti-Par-6, anti-aPKC
antibody or anti-Par-3 antibody. Data shown are representative of three
independent experiments.
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real-time PCR were as follow:
Par-3: sense 5′-GAAGTCCCAAAACCTGCGACAG-3′
antisense 5′-CTCCAGCCACCGGTCTACCATT-3′
GAPDH: sense 5′-CCCGCAGCCTCGTCTCATAGA-3′
antisense 5′-CTTCGGCCACCCTATCCAC-3′.
Reaction conditions were as follow: 95 °C for 2 min for UDG incubation and
95 °C for 10 min for UDG inactivation and DNA polymerase activation , then 40
repeats of 95 °C for 15 s, 62 °C for 1 min and each sample was performed triply
in 25 μl reaction volume. GAPDH was used as reference gene. Relative
quantification of gene expression was performed using the 2−ΔΔCt method based
on Ct values for both target and reference genes. In order to calculate the fold
increase, results of real-time PCR analysis are given as mean±SD.
2.4. Immunoprecipitation and Western blot analysis
NRK52E cells were washed with PBS and scraped into lysis buffer (50 mM
Hepes pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mMMgCl2,
1 mM EGTA, 10 mM NaF, 10 mM Na4P2O7, 1 mM Na3VO5, 1 mM phenyl-
methylsulfonyl fluoride, 10 μg/ml leupeptin and 20 μg/ml aprotinin). Protein
was quantified by the Bradford assay (BioRad, Hercules, CA). To immunopre-
cipitate endogenous complex of Par-3 and Par-6, polyclonal anti-Par-6 antibody
was incubated with cell lysates at 4 °C, followed by incubation with Protein-A-
sepharose beads for 90 min at 4 °C. Immunoprecipitates were washed three
times with lysis buffer and then subjected to 10% SDS-PAGE, and transferred
onto nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ). After
blocking in 5% skim milk for 1 h at room temperature, the membranes were
incubated with indicated primary antibody at 4 °C overnight followed by
horseradish peroxidase-conjugated second antibody for 1 h at room temperature
and detected by chemiluminescence (Amersham Life Science).
To prepare NP-40 insoluble fractions, the cells were lysed in 700 μl of ice-
cold NP-40 IP buffer (25 mM Hepes/NaOH, pH7.4, 150 mM NaCl, 1% NP-40,
4 mM EDTA, 50 mM NaF, 1 mM Na3VO5, 1 mM PMSF, 10 μg/ml leupeptin
and 2 μg/ml aprotinin) by 30 min rotation at 4 °C. After centrifugation the pellet
was redissolved in 87.5 μl of 2× SDS-sample buffer, and then subjected to
Western blot with anti-Par-6 antibody.
2.5. Immunofluorescence staining
NRK52E cells grown on glass coverslips were fixed in 2% paraformalde-
hyde for 15 min at 4 °C. After washing, cells were permeabilized in PBS
containing 0.1% Triton X-100 for 5 min and then blocked with PBS containing
10% BSA for 30 min at room temperature. Cells were incubated overnight at
4 °C with indicated primary antibodies diluted in PBS (anti-Par-3 1:200, anti-E-
cadherin 1:500, anti-α-SMA 1:500) containing 0.1% bovine serum albumin
followed by detection with either FITC-conjugated goat anti-rabbit, FITC-
conjugated goat anti-mouse or Cy3-conjugated donkey anti-mouse antibody in
5% BSA in PBS for 2 h at room temperature. Samples were mounted in fixation
medium (Biomeda, Foster City, CA). Images were analyzed and collected with
Zeiss LSM 510 Confocal Imaging System (Zeiss, Germany).
2.6. Statistics
The results were expressed as mean±SD from at least three experiments.
Statistical analysis was carried out using SPSS11.0. Data were analyzed using one-
wayANOVA followed by post-hoc test. A pb0.05was considered to be significant.
3. Results
3.1. TGF-β1 induces EMT in NRK52E cells and downregulates
Par-3 expression
First of all, we assayed, by Western blot, for the amount of
Par-3 protein in the lysate of NRK52E cells which werecollected at various time points after TGF-β1 treatment. As
seen in Fig. 1, TGF-β1 treatment led to a gradual decrease with
time in the level of E-cadherin over 72 h. In contrast, the level of
α-SMA increased drastically with TGF-β1 treatment for 24 h and
reached a plateau up to 72 h. Meanwhile, the amount of Par-3
started to decrease at 48 h after TGF-β1 treatment and plum-
meted to a level approximately 50% of that for the untreated cells
at 72 h (Fig. 1).
To further investigate whether TGF-β1-induced Par-3 down-
regulation in NRK52E cells was dose-dependent, we treated the
cells with incremental concentrations of TGF-β1 from 2.5 to
20 ng/ml and assayed for Par-3 protein levels at 72 h after TGF-
β1 treatment. The level of Par-3 decreased progressively with
55X. Wang et al. / Biochimica et Biophysica Acta 1782 (2008) 51–59increased concentrations of TGF-β1. At 20 ng/ml of TGF-β1,
Par-3 was decreased to approximately 30% of that in the control
(untreated) cells (Fig. 2).
TGF-β1 could regulate Par-3 level either at the mRNA level
or post-translationally. To determine this, we next examined the
Par-3 transcript during TGF-β1-induced tubular EMT by real-
time PCR. As shown in Fig. 3, Par-3 mRNA was gradually
decreased after TGF-β1 treatment in NRK52E cells, 10 ng/ml
TGF-β1 treatment for 72 h resulted in a significant decrease of
Par-3 transcript compared with that from cells treated with TGF-
β1 for 24 h.
We further confirmed the effect of TGF-β1 treatment on the
cellular morphology and expression of Par-3 in NRK52E cells
by the immunofluorescence technique. Incubation of the cells
with 10 ng/ml TGF-β1 for 72 h resulted in a significant loss of
their epithelial phenotype and the cells displayed a fibroblast-
like morphology identifiable by the presence of elongated
lamellipodia (Fig. 4A and B). To further characterize this cell
morphological transition, we performed immunofluorescence
staining of treated and untreated cells for examining variousFig. 6. Overexpression of Par-3 inhibited TGF-β1-induced EMT. (A) Overexpressio
TGF-β1. NRK52E cells were transiently transfected with either pKH3-HA-Par-3 or p
quantitated to equivalent amounts of protein resolved by SDS-PAGE and immun
monoclonal anti-HA antibody. GAPDH was used to verify equivalent loading. (B)
attenuated TGF-β1-induced α-SMA expression. NRK52E cells were transiently trans
of TGF-β1 treatment for 72 h, and then cellular lysates were harvested to detect E-cad
cells; (T) untransfected cells treated with TGF-β1; (V) pKH3 empty vector-transfec
TGF-β1. E-cadherin/GAPDH ratio was given as mean±SD from three independ
⁎pb0.05 compared to both TGF-β1-treated untransfected group and TGF-β1-treateEMTmarkers. As shown in Fig. 4C andD,most TGF-β1-treated
cells lost the regular staining pattern and are characterized by a
complete loss or fragmented staining of E-cadherin at the cell–
cell junctions, whereas untreated cells exhibit a normal staining
pattern for E-cadherin at the cell–cell junctions. To corroborate
this observation, we stained the same cells for the mesen-
chymal marker α-SMA. Most untreated cells stained negative
for α-SMA as expected. In contrast, approximately half of the
TGF-β1-treated cells were marked by strong α-SMA staining
(Fig. 4E and F), and the pattern of staining was consistent with
these cells acquiring a fibroblast-like phenotype. These data
strongly suggest that NRK52E cells underwent EMTat prolonged
TGF-β1 treatment. To find out the localization of Par-3 during
EMT, we immunostained endogenous Par-3 in NRK52E cells
before or after TGF-β1 treatment (Fig. 4G and H). While Par-3
was detected prominently at the cell–cell junctions in normal
NRK52E cells, it was significantly reduced in TGF-β1-treated
cells. Since many of the latter cells showed diffused cytosolic
staining for Par-3, it is also likely that Par-3 relocates from the
cell–cell junctions to cytosol during EMT. Taken together, thesen of Par-3 did not affect E-cadherin and α-SMA expressions in the absence of
KH3 empty vectors. 48 h after transfection, whole cellular lysates were prepared,
oblotted with indicated antibodies. Overexpression of Par-3 was detected by
Overexpression of Par-3 blocked TGF-β1-induced E-cadherin suppression and
fected with either pKH3-HA-Par-3 or pKH3 empty vectors followed by 10 ng/ml
herin, α-SMA and Par-3 expressions by Western blot analysis. (C) untransfected
ted cells treated with TGF-β1; (P) pKH-HA-Par-3-transfected cells treated with
ent experiments. #pN0.05 compared to TGF-β1-treated untransfected group,
d empty vector-transfected group.
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time- and dose-dependent manner in NRK52E cells.
3.2. TGF-β1 treatment disrupts Par complex
Par-3 is a critical component of Par complex that targets Par
complex to cell membrane [8,9], we thus examined the effect of
the downregulation of Par-3 on other components of Par
complex. By using Western blot analysis, we found that the
protein level of neither Par-6 nor aPKC was changed by TGF-
β1(10 ng/ml) treatment (Fig. 5A). We next examined the
distribution of Par-6. As shown in Fig. 5B lines 1 and 2, there is
no significant change of total amount of Par-6 in NRK52E cells
upon TGF-β1 treatment, which is consistent with a previous
report [20], but TGF-β1 treatment caused a remarkable decline
of Par-6 in NP-40 insoluble fraction (Fig. 5B lines 3 and 4) and
an increase of Par-6 in NP-40 soluble fraction (Fig. 5B lines 5
and 6). These results suggest that TGF-β1 treatment caused a
redistribution of Par-6 from cell membrane to cytosol.Fig. 7. Stable transfection of Par-3 into NRK52E cells partially blocked TGF-β1-
microscopy images showing Par-3 (A, B), E-cadherin (C, D) and α-SMA (E, F) immu
D, F) stably expressing NRK52E cells upon TGF-β1 treatment for 72 h.We further performed immunoprecipitation to test the
integrity of Par-3 with Par-6 and aPKC. The endogenous Par-6
was immunoprecipitated from either TGF-β1-treated or
untreated cells, and then immunoblotted with either anti-Par-3
or anti-aPKC antibody. As shown in Fig. 5C, the amount of Par-3
co-precipitated with Par-6 was remarkably reduced after TGF-
β1 treatment, but the amount of aPKC associated with Par-6
remained unchanged. This result suggests that TGF-β1 treat-
ment did not affect the association between Par-6 and aPKC.
Taken together, these data imply that the downregulation of
Par-3 by TGF-β1 treatment disrupted the Par complex on
cellular membrane and redistributed Par-6–aPKC complex into
the cytosol.
3.3. Overexpression of Par-3 blocks TGF-β1-induced EMT
Since Par-3 expression was decreased by TGF-β1 in EMT,
we next investigated whether overexpression of Par-3 would
affect the progress of EMT. HA-tagged Par-3 was transientlyinduced Par-3, E-cadherin suppression and α-SMA induction. Laser confocal
nofluorescence in both control NRK52E cells (A, C, E) and pKH3-HA-Par-3 (B,
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confirmed byWestern blot using an anti-HA antibody (Fig. 6A).
Expression of HA–Par-3 did not affect the protein level of E-
cadherin or α-SMA in untreated NRK52E cells (Fig. 6A).
Because E-cadherin is an epithelial marker that plays an essential
role in the maintenance of cell junctions, and its loss is the
earliest key cellular event during EMT, we next examined the
effect of Par-3 overexpression on the cellular level of E-cadherin
following TGF-β1 treatment. As shown in Fig. 6B, E-cadherin
level was reduced after 10 ng/ml TGF-β1 treatment for 72 h in
either untransfected cells (line “T”, Fig. 6B) or cells trans-
fected with the empty vector (line “V”, Fig. 6B). Overexpres-
sion of Par-3 partially blocked the ability of TGF-β1 to suppress
E-cadherin expression (line “P”, Fig. 6B). In a parallel ex-
periment, we found that overexpression of Par-3 significantly
decreased TGF-β1-induced α-SMA expression (Fig. 6B).
To further examine the effect of overexpression of Par-3 on
E-cadherin and α-SMA expressions by immunofluorescence
staining, we generated stably expressing Par-3 NRK52E cell
line. Compared with control cells, Par-3 overexpressed cells
were resistant to TGF-β1 treatment and partially retained both
E-cadherin and Par-3 staining at the cell–cell junction. More-Fig. 8. Knockdown Par-3 expression by siRNA promoted TGF-β1-induced EMT. (A)
as described in Materials and methods. Cells were lysed and Western blot was perform
were transiently transfected with either Par-3 or non-targeting siRNA followed by
expression of E-cadherin and α-SMA by Western blot analysis. E-cadherin/GAPDH r
experiments. (C) untransfected cells; (T) untransfected cells treated with TGF-β1; (N
transfected cells treated with TGF-β1. #pN0.05 compared to TGF-β1-treated untran
and TGF-β1-treated non-targeting siRNA-transfected group.over, the number of cells positive for α-SMA staining was
significantly reduced in Par-3 overexpressed cells (Fig. 7).
3.4. Knockdown Par-3 expression promoted TGF-β1-induced
tubular EMT
To further confirm the role of Par-3 in EMT, we knocked down
Par-3 expression by siRNA inNRK52E cells. As shown in Fig. 8A,
depletion of Par-3 did not affect the protein level of E-cadherin and
α-SMA. TGF-β1 treatment resulted in a decrease of E-cadherin
expression and an induction of α-SMA expression. How-
ever, compared with non-targeting control siRNA-transfected
cells, E-cadherin expression was further reduced in Par-3 defi-
cient cells after 10 ng/ml of TGF-β1 treatment for 72 h. Mean-
while, Par-3 knockdown dramatically enhanced TGF-β1-induced
α-SMA expression (Fig. 8B). Collectively, these results indicate
that Par-3 plays a protective role inTGF-β1-induced tubular EMT.
4. Discussion
In the present study, we have demonstrated that TGF-β1
downregulated Par-3 protein expression in a dose- and time-NRK52E cells were transiently transfected with Par-3 and non-targeting siRNA
ed to detect the expression of Par-3, E-cadherin and α-SMA. (B) NRK52E cells
TGF-β1 treatment for 48 h, and then cell lysates were harvested to detect the
atio and α-SMA/GAPDH ratio were given as mean±SD from three independent
) non-targeting siRNA-transfected cells treated with TGF-β1; (P) Par-3 siRNA-
sfected group, ⁎pb0.05 compared to both TGF-β1-treated untransfected group
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caused a subsequent disruption of Par complex at the cell
membrane and the redistribution of the dissociated Par-6–aPKC
complex into cytoplasm. Overexpression of Par-3 could
partially block TGF-β1-induced tubular EMT.
Lines of in vitro and in vivo evidence indicate that TGF-β is
a key initiator and promoter of EMT. Most studies suggest that
TGF-β exerts its role mainly through regulating gene expres-
sion via Smad signaling pathway. Disruption of cell–cell
contact is the first step of EMTand previous studies have shown
that TGF-β suppresses gene expression of adhesion junction
marker E-cadherin and tight junction protein ZO-1, claudin and
occludin [21–23]. Lack of these transmembrane proteins would
thus result in the disassembly of cell–cell adhesion. Consistent
with previous studies, our study showed that TGF-β1 down-
regulated Par-3 expression in a time- and dose-dependent
manner at transcription level.
Cell junction consists of transmembrane proteins such as
occludin, claudins and E-cadherin which are organized in
intramembranous strands. These membrane proteins associate
with a cytoplasmic plaque composed of a variety of peripheral
membrane proteins including membrane-associated guanylate
kinase (MAGUK) family of proteins ZO-1, -2, -3 or catenines
that help to link membrane proteins to actin cytoskeleton.
Recently, a couple of protein complexes such as Par complex,
Scrib–Dlg–Lgl complex and Crumbs–Pals–Patj complex have
emerged as important signaling proteins that regulate cell
polarity in various organisms ranging from worms to mammals
[8–10]. Despite the well recognized function of TGF-β on the
regulation of transmembrane proteins, its role in these signaling
complexes remains unclear. For the first time, we found that
TGF-β1 downregulated the protein level of Par-3 and further
dissociated Par complex during the process of EMT, suggesting
that disassembly of Par complex is one of the possible
mechanisms that TGF-β1 disrupts cell junction in EMT.
Recently, Ozdamar et al. have reported that TGF-β1 regulated
the phosphorylation of Par-6. Phosphorylated Par-6 then
recruits the ubiquitin ligase Smurf1 to the receptor and leads
to localized degradation of the RhoA GTPase which is required
for the disruption of tight junction during EMT [20]. Since Par-
3 interacts with Par-6, we speculate that the downregulation of
Par-3 by TGF-β releases Par-6 and thus allows it to be
phosphorylated by TGF-β.
In epithelial cells, the Par complex plays an important role as
a modulator of tight junction homeostasis and apical–basal
polarity, with Par-3 as a key component of this complex.
Suppression of Par-3 expression by RNA interference resulted
in a dramatic disruption of TJ in mammalian epithelial cell [24].
Most recently, Gopalakrishnan et al. reported that disruption of
tight junction during ATP depletion involved the reduction of
Par-3 phosphorylation and dysfunction of Par complex in
MDCK cells [25]. These results are in accordance with our
observation that Par-3 is downregulated during the process of
TGF-β1-initiated tubular EMT when epithelial cells lose their
polarity.
Taken together, disruption of cell junction by TGF-β1 during
EMT could involve the disassembly of signaling complex suchas Par complex as well as the downregulation of transmembrane
protein expression. A more detailed understanding of the effect
of TGF-β1 on these signaling complexes will help identify
novel therapeutic targets and new therapeutic intervention
approaches for EMT.
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